All In Biotech

Drug Trial Radar · NCT00489398

Comparison of CL Wear Between Two Allergy Drops

Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride

Last checked: Nov 19, 2026Latest source record: Oct 7, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

25

Planned (sponsor's estimate)

Start

Jul 2007

Primary completion

Not stated

Study completion Dec 2008

Sponsor

Lead sponsor
Hom, Milton M., OD, FAAOIndividual
Sponsor type
Individual
Collaborators
Merck Sharp & Dohme LLC
First posted
Jun 21, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

Conditions

  • Allergic Conjunctivitis

Interventions

  • epinastine HCL and olopatadine HCLDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Contact lens objective and subjective clinical performance testingTime frame: up to 3 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.